The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 245-249

  Yamauchi, Takeyoshi ^a   Watanabe, Masahiko ^a   Hasegawa, Hirotoshi ^a   Nishibori, Hideki ^a   Ishii, Yoshiyuki ^a   Tatematsu, Hideki ^a   Yamamoto, Kentaro ^a   Kubota, Tetsuro ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2 (COX 2); Human colorectal cancer cell lines; Liver metastasis; Selective COX 2 inhibitor

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GELATIN; MATRIX METALLOPROTEINASE; TILMACOXIB; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BENZENESULFONATES; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENDOTHELIAL GROWTH FACTORS; HT29 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LIVER NEOPLASMS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MICE; MICE, SCID; OXAZOLES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037234156     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Thun MJ, Namboodiri MM and Heath CWJ: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596, 1991.
2. Waddell WR and Loughry RW: Sulindac for polyposis of the colon. J Surg Oncol 24: 83-87,1983.
3. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
4. Tsujii M and DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
5. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998.
6. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997.
7. Yamauchi T, Watanabe M, Kubota T, Hasegawa H, Ishii Y, Endo T et al: Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum 45: 98-103, 2002.
8. Matsushita M, Masaki M, Yagi Y, Tanaka T and Wakitani K: Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 46: 461-466, 1997.
9. Yasui N, Sakamoto M, Ochiai A, Ino Y, Akimoto S and Orikasa A: Tumor growth and metastasis of human colorectal cancer cell lines in SCID mice resemble clinical metastatic behaviors. Invasion Metastasis 17: 259-269, 1997.
10. Hla T and Neilson K: Human cyclooxygenase-2 cDNA. Proc Acad Sci USA 89: 7384-7388, 1992.
11. Mainiero F, Pepe A, Yeon M, Ren Y and Giancotti FG: The intracellular functions of alpha6beta4 integrin are regulated by EGF. J Cell Biol 134: 241-253, 1996.
12. Bernhard E, Muschel RJ and Hughes EN: Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50: 3872-3877, 1990.
13. Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J et al: Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049, 1995.
14. Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J et al: Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 81: 1274-1279, 1999.
15. Sheng H, Shao I, Kirkland SC, Isakson P, Coffey RJ, Morrow J et al: Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259, 1997.
16. Williams CS, Watson AJM, Sheng H, Helou R, Shao J and DuBois RN: Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res 60: 6045-6051, 2000.
17. Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E et al.: Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61: 1733-1740, 2000.
18. Fidler IJ: Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50: 6130-6138, 1990.
19. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
20. Bruns CJ, Liu W, Davis DW, Shahee RM, McConkey DJ, Wilson MR et al.: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89: 488-499, 2000.
21. Kondo Y, Arii S, Mori A, Furutani M, Chiba T and Imamura M: Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into human colon cancer cell line. Clin Cancer Res 6: 622-630, 2000.
22. Brand K, Baker AH, Perez - Canto A, Possling A, Sacharjat M, Geheeb M et al.: Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 60: 5723-5730, 2000.